SPSB1 promotes breast cancer recurrence by potentiating c-MET signaling.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Cancer Discovery

• Publication date

  2014-04-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/2159-8290.CD-13-0548PMID 24786206PMCID PMC4121738
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Par-4 downregulation promotes breast cancer recurrence by preventing multinucleation following targeted therapy.

  2013cited by this paper
• Breast cancer subtypes and the risk of local and regional relapse.

  2010cited by this paper
• Preexistence and clonal selection of MET amplification in EGFR mutant NSCLC.

  2010cited by this paper
• Corrigendum to “Discovery and optimization of potent and selective triazolopyridazine series of c-Met inhibitors” [Bioorg. Med. Chem. Lett. 19 (2009) 6307]

  2010cited by this paper
• The SPRY domain–containing SOCS box protein SPSB2 targets iNOS for proteasomal degradation

  2010cited by this paper
• Molecular Profiling of Breast Cancer Cell Lines Defines Relevant Tumor Models and Provides a Resource for Cancer Gene Discovery

  2009cited by this paper
• The Snf1-related kinase, Hunk, is essential for mammary tumor metastasis

  2009cited by this paper
• Discovery and optimization of potent and selective triazolopyridazine series of c-Met inhibitors.

  2009cited by this paper
• Mechanisms of Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small Cell Lung Cancer

  2008cited by this paper
• Key Issues in Conducting a Meta-Analysis of Gene Expression Microarray Datasets

  2008cited by this paper
• Docetaxel, cisplatin, and trastuzumab as primary systemic therapy for human epidermal growth factor receptor 2-positive locally advanced breast cancer.

  2006cited by this paper
• Isoform-Specific Ras Activation and Oncogene Dependence during MYC- and Wnt-Induced Mammary Tumorigenesis

  2006cited by this paper
• CellProfiler: image analysis software for identifying and quantifying cell phenotypes

  2006cited by this paper
• Structural basis for protein recognition by B30.2/SPRY domains.

  2006cited by this paper
• Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer.

  2005cited by this paper
• Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors

  2005cited by this paper
• The SPRY Domain-containing SOCS Box Protein 1 (SSB-1) Interacts with MET and Enhances the Hepatocyte Growth Factor-induced Erk-Elk-1-Serum Response Element Pathway*

  2005cited by this paper
• The transcriptional repressor Snail promotes mammary tumor recurrence.

  2005cited by this paper
• Lack of sustained regression of c-MYC-induced mammary adenocarcinomas following brief or prolonged MYC inactivation.

  2004cited by this paper
• Impact of p53 loss on reversal and recurrence of conditional Wnt-induced tumorigenesis.

  2003cited by this paper
• Conditional activation of Neu in the mammary epithelium of transgenic mice results in reversible pulmonary metastasis.

  2002cited by this paper
• A novel doxycycline‐inducible system for the transgenic analysis of mammary gland biology

  2002influential reference
• c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations

  2001cited by this paper
• A general parametric approach to the meta-analysis of randomized clinical trials.

  1991cited by this paper
• Meta-analysis in clinical trials.

  1986cited by this paper

• Causal Relationship Between Galectins With Neuroblastoma: A Mendelian Randomization Study

  2025cites this paper
• Targeting dormant tumor cells to prevent recurrent breast cancer: a randomized phase 2 trial

  2025cites this paper
• Testis-enriched Spsb1 is not required for spermatogenesis and fertility in mice.

  2025cites this paper
• DTC-Flow: a flow cytometry-based detection platform for characterizing bone marrow disseminated tumor cells in breast cancer

  2025cites this paper
• Autophagy is required for mammary tumor recurrence by promoting dormant tumor cell survival following therapy

  2024cites this paper
• Optical imaging reveals chemotherapy-induced metabolic reprogramming of residual disease and recurrence

  2024cites this paper
• Single-cell RNA sequencing reveals intratumoral heterogeneity and potential mechanisms of malignant progression in prostate cancer with perineural invasion

  2023cites this paper
• Function, mechanism and drug discovery of ubiquitin and ubiquitin-like modification with multiomics profiling for cancer therapy

  2023cites this paper
• Dormancy in Breast Cancer.

  2023cites this paper
• B3GALT6 Promotes Dormant Breast Cancer Cell Survival and Recurrence by Enabling Heparan Sulfate-Mediated FGF Signaling

  2023cites this paper
• PAQR8 promotes breast cancer recurrence and confers resistance to multiple therapies

  2023cites this paper
• In vivo metabolic imaging identifies lipid vulnerability in a preclinical model of Her2+/Neu breast cancer residual disease and recurrence

  2022cites this paper
• Transcriptome Variant Analysis of Noise Susceptibility in C57BL/6J Mice

  2022cites this paper
• Temporal and spatial topography of cell proliferation in cancer

  2021cites this paper
• Gene expression profiling after LINC00472 overexpression in an NSCLC cell line

  2021cites this paper
• Cellular dormancy in minimal residual disease following targeted therapy

  2021cites this paper
• S-(−)-Oleocanthal as a c-Met receptor tyrosine kinase inhibitor and its application to synergize targeted therapies and prevent breast cancer recurrence

  2021cites this paper
• Context-dependent effects of whole-genome duplication during mammary tumor recurrence

  2021cites this paper
• Cancer classification and biomarker selection via a penalized logsum network-based logistic regression model

  2021cites this paper
• A tumor acidity activatable and Ca2+-assisted immuno-nanoagent enhances breast cancer therapy and suppresses cancer recurrence

  2020cites this paper
• G9a Promotes Breast Cancer Recurrence through Repression of a Pro-inflammatory Program

  2020influential citation
• Adaptation and Selection Shape Clonal Evolution During Residual Disease and Recurrence

  2020cites this paper
• NRF2 activation promotes the recurrence of dormant tumour cells through regulation of redox and nucleotide metabolism

  2020cites this paper
• In vivo metabolic imaging reveals mitochondrial membrane potential reprogramming following Her2-targeted therapy and dormant disease

  2020cites this paper
• Adaptation and selection shape clonal evolution of tumors during residual disease and recurrence

  2020cites this paper
• Epithelial-to-mesenchymal transition activates Bcat1 expression to promote recurrent tumor growth

  2020cites this paper
• NRF2 activation promotes the recurrence of dormant tumour cells through regulation of redox and nucleotide metabolism

  2020cites this paper
• Cullin-5 Adaptor SPSB1 Controls NF-κB Activation Downstream of Multiple Signaling Pathways

  2019cites this paper
• A Novel Cox Proportional Hazards Model for High-Dimensional Genomic Data in Cancer Prognosis

  2019cites this paper
• MALAT1 regulates miR-34a expression in melanoma cells

  2019cites this paper
• NRF2-dependent metabolic reprogramming is required for tumor recurrence following oncogene inhibition

  2019cites this paper
• Optical Imaging of Glucose Uptake and Mitochondrial Membrane Potential to Characterize Her2 Breast Tumor Metabolic Phenotypes

  2019cites this paper
• Impact of obesity on breast cancer recurrence and minimal residual disease

  2019influential citation
• SPSB1 enhances ovarian cancer cell survival by destabilizing p21.

  2019cites this paper
• Integrative analysis of copy number and gene expression data identifies potential oncogenic drivers that promote mammary tumor recurrence

  2019cites this paper
• Increased Expression of c-Met is Associated with Chemotherapy-Resistant Breast Cancer and Poor Clinical Outcome

  2018cites this paper
• Foxo-dependent Par-4 Upregulation Prevents Long-term Survival of Residual Cells Following PI3K–Akt Inhibition

  2018cites this paper
• SPSB1-mediated HnRNP A1 ubiquitylation regulates alternative splicing and cell migration in EGF signaling

  2017cites this paper
• The women in steady exercise research (WISER) survivor trial: The innovative transdisciplinary design of a randomized controlled trial of exercise and weight-loss interventions among breast cancer survivors with lymphedema.

  2017cites this paper
• Cullin 5-RING E3 ubiquitin ligases, new therapeutic targets?

  2016cites this paper
• Post-translational deregulation of YAP1 is genetically controlled in rat liver cancer and determines the fate and stem-like behavior of the human disease

  2016influential citation
• Cotylenin A and arsenic trioxide cooperatively suppress cell proliferation and cell invasion activity in human breast cancer cells.

  2015cites this paper
• NOP14 suppresses breast cancer progression by inhibiting NRIP1/Wnt/β-catenin pathway

  2015cites this paper
• SPSB1 may have MET its match during breast cancer recurrence.

  2014cites this paper
• SPSB 1 May Have MET Its Match during Breast Cancer Recurrence

  2014cites this paper
• Modeling breast cancer dormancy and recurrence following oncogenic pathway inhibition

  2014cites this paper